Krilogy Financial’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
3,885
-1,194
-24% -$79.5K 0.01% 874
2026
Q1
$311K Sell
5,079
-988
-16% -$68.8K 0.01% 728
2025
Q4
$445K Buy
+6,067
New +$392K 0.02% 600

Other funds holding DXCM

Krilogy Financial's DXCM Position: Q2 2026 in Review

Krilogy Financial reduced its DexCom (DXCM) stake by 24% in Q2 2026, selling an estimated $79.5K and leaving 3,885 shares worth $262K. The position accounts for 0.01% of the portfolio, ranked #874.

Krilogy Financial first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. The position peaked at $445K in Q4 2025. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Krilogy Financial held 3,885 shares of DexCom worth $262K as of Q2 2026.
  • Krilogy Financial sold 1,194 DexCom shares in Q2 2026, an estimated $79.5K.
  • DexCom made up 0.01% of Krilogy Financial's portfolio in Q2 2026, its #874 holding.
  • Krilogy Financial first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
  • Krilogy Financial's DexCom position peaked at $445K in Q4 2025.
  • 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.